161 related articles for article (PubMed ID: 37147148)
1. Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
Long H; Shi MH; Li X
J Fr Ophtalmol; 2023 Oct; 46(8):929-940. PubMed ID: 37147148
[TBL] [Abstract][Full Text] [Related]
2. Interventions to slow progression of myopia in children.
Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
[TBL] [Abstract][Full Text] [Related]
3. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis.
Ha A; Kim SJ; Shim SR; Kim YK; Jung JH
Ophthalmology; 2022 Mar; 129(3):322-333. PubMed ID: 34688698
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis.
Hou P; Wu D; Nie Y; Wei H; Liu L; Yang G
Front Pharmacol; 2023; 14():1227787. PubMed ID: 37767401
[No Abstract] [Full Text] [Related]
6. Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children.
Zhu Q; Tang Y; Guo L; Tighe S; Zhou Y; Zhang X; Zhang J; Zhu Y; Hu M
Int J Med Sci; 2020; 17(2):176-181. PubMed ID: 32038101
[No Abstract] [Full Text] [Related]
7. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
[TBL] [Abstract][Full Text] [Related]
9. Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study.
Chia A; Ngo C; Choudry N; Yamakawa Y; Tan D
Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):370-376. PubMed ID: 37523428
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.
Gong Q; Janowski M; Luo M; Wei H; Chen B; Yang G; Liu L
JAMA Ophthalmol; 2017 Jun; 135(6):624-630. PubMed ID: 28494063
[TBL] [Abstract][Full Text] [Related]
11. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
[TBL] [Abstract][Full Text] [Related]
13. Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression.
Pérez-Flores I; Macías-Murelaga B; ; Barrio-Barrio J
Sci Rep; 2023 Sep; 13(1):16310. PubMed ID: 37770602
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
[TBL] [Abstract][Full Text] [Related]
16. Interventions to slow progression of myopia in children.
Walline JJ; Lindsley K; Vedula SS; Cotter SA; Mutti DO; Twelker JD
Cochrane Database Syst Rev; 2011 Dec; (12):CD004916. PubMed ID: 22161388
[TBL] [Abstract][Full Text] [Related]
17. Analysis of treatment response about low-dose (0.01%) atropine eye-drops in myopic children.
Jeon GS; Hong IH; Lee JH; Song TG; Lee TY; Han JR
Eur J Ophthalmol; 2022 Jul; 32(4):2011-2017. PubMed ID: 34399596
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
[TBL] [Abstract][Full Text] [Related]
19. Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial.
Sharma I; Das GK; Rohatgi J; Sahu PK; Chhabra P; Bhatia R
Curr Eye Res; 2023 Apr; 48(4):402-407. PubMed ID: 36576170
[TBL] [Abstract][Full Text] [Related]
20. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
Chia A; Lu QS; Tan D
Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
